BiomX is a biotechnology company developing phage therapies for eradicating bacteria associated with chronic diseases that is headquartered in Ness Ziona, Israel and was founded in 2015 by Eran Elinav, Rotem Sorek, Timothy K. Lu, and Timothy Lu.
On May 15, 2017 BiomX completed their series A funding round with $24 million in funding from Takeda Ventures (lead investor), OrbiMed (lead investor), Johnson & Johnson Innovation (lead investor), Seventure Partners, SBI Japan-Israel Innovation Fund, and Mirae Asset Financial Group.
On February 20, 2019 BiomX completed their series A funding round with $32 million in funding from Seventure Partners (lead investor), RM Global Partners (lead investor), Takeda Ventures, SBI Japan-Israel Innovation Fund, OrbiMed, KB Investment, Johnson & Johnson Innovation, Handok, Consensus Business Group, and Chong Kun Dang Pharmaceutical Corp.
BiomX raises a $32,000,000 series B round from MiraeAsset, 8VC, RM Global Partners, OrbiMed, Seventure Partners, Johnson & Johnson Innovation – JJDC, Mirae Asset Financial Group, Takeda Ventures and Johnson & Johnson.
BiomX raises a $24,000,000 series A round from SBI Japan-Israel Innovation Fund, Johnson & Johnson Innovation, Mirae Asset Venture Investment, OrbiMed, Seventure Partners and Takeda Ventures.
BiomX was founded.
Documentaries, videos and podcasts
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.